share_log

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

bio-rad實驗室股票交易上漲,花旗集團維持對該股票的買入評級,並將其價格目標從400美元上調至450美元。
Benzinga ·  11/02 03:21

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

bio-rad實驗室股票交易價格上漲,因爲花旗集團維持對該股的買入評級,並將其目標價格從400美元上調至450美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論